Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
VRTX
Financials
Revenue by region
VRTX
Vertex Pharmaceuticals Incorporated
Backtest
VRTX
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by product
Revenue by region
Gross profit
Operating income
Net income
EPS
EBITDA
Cash flow
Balance sheet
Valuation
Shares and dividends
Costs
Revenue by region
Annual
Quarterly
Revenue by region
Annual
Quarterly
2025, ended Dec 31, 2025
United States
$7.5B
63%
Europe
$3.5B
29%
Other (revenues outside of the United States)
$992M
8%
Regions by fiscal year
CSV
Regions by fiscal year
USD
Line, in USD
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
United States
7.55B
6.68B
6.04B
5.70B
5.29B
4.83B
3.06B
2.37B
1.99B
1.32B
0.76B
0.36B
0.90B
1.37B
1.39B
revenues outside of the United States
4.45B
4.34B
3.83B
3.23B
2.29B
1.38B
1.10B
0.68B
0.50B
0.38B
0.27B
0.22B
0.32B
0.15B
21M
Europe
3.46B
3.45B
3.11B
2.71B
1.97B
1.13B
0.89B
0.54B
0.42B
0.32B
0.22B
0.20B
0.28B
0.13B
20M
Other (revenues outside of the United States)
992M
881M
720M
526M
313M
250M
215M
139M
82M
60M
49M
22M
35M
24M
769K
Earlier
Other
—
—
—
—
1.00M
2.90M
2.10M
—
—
—
—
—
—
—
—
Total
12.0B
11.0B
9.9B
8.9B
7.6B
6.2B
4.2B
3.0B
2.5B
1.7B
1.0B
580M
1.2B
1.5B
1.4B
More Vertex Pharmaceuticals financials
Revenue
Revenue by product
Gross profit
Operating income
Net income
EPS
Revenue at other companies
CVS
CVS Health Corporation
MCK
McKesson Corporation
BSX
Boston Scientific Corporation
ILMN
Illumina, Inc.
NTRA
Natera, Inc.
ELV
Elevance Health, Inc.
Tools
Return calculator